2012
DOI: 10.1378/chest.11-2552
|View full text |Cite
|
Sign up to set email alerts
|

Prognostic Significance of the Extent of Visceral Pleural Invasion in Completely Resected Node-Negative Non-small Cell Lung Cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

3
32
0

Year Published

2012
2012
2021
2021

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 37 publications
(35 citation statements)
references
References 28 publications
3
32
0
Order By: Relevance
“…24 2000–2009TurkeyNAI-IVNA96343742.5%H&E and elastic stainingAC and SCCLobectomy/bilobectomy pneumonectomy lobectomy + chest wall resection and pneumonectomy + chest wall resectionNo7Chang Y. L. 11 1990–2008Taiwan64I-IIINANA151170H&E and elastic stainingAC, SCC and ASCLobectomyYes7Hung J. J. 12 1990–2006Taiwan67I-II4.5NA30055H&E and elastic stainingAC, SCC, LCCs and othersPneumonectomy bilobectomy, lobectomy and sublobar resectionNo7Kudo Y. 14 2000–2007Japan66I-III4.66921326221.9%H&E and elastic stainingAC, SCC, LCC and othersPneumonectomy bilobectomy and lobectomyYes7Hung J. J.…”
Section: Resultsmentioning
confidence: 99%
See 3 more Smart Citations
“…24 2000–2009TurkeyNAI-IVNA96343742.5%H&E and elastic stainingAC and SCCLobectomy/bilobectomy pneumonectomy lobectomy + chest wall resection and pneumonectomy + chest wall resectionNo7Chang Y. L. 11 1990–2008Taiwan64I-IIINANA151170H&E and elastic stainingAC, SCC and ASCLobectomyYes7Hung J. J. 12 1990–2006Taiwan67I-II4.5NA30055H&E and elastic stainingAC, SCC, LCCs and othersPneumonectomy bilobectomy, lobectomy and sublobar resectionNo7Kudo Y. 14 2000–2007Japan66I-III4.66921326221.9%H&E and elastic stainingAC, SCC, LCC and othersPneumonectomy bilobectomy and lobectomyYes7Hung J. J.…”
Section: Resultsmentioning
confidence: 99%
“…Only three studies contributed data to the analyses of recurrence-free survival 12, 19, 31 . Two studies compared recurrence-free survival between PL1 and PL0 patients 19, 31 , two studies compared PL2 with PL0 patients 19, 31 and two studies compared PL2 with PL1 patients 12, 19 .…”
Section: Resultsmentioning
confidence: 99%
See 2 more Smart Citations
“…In patients with tumors ≤3 cm, when analyzed according to pl0, pl1, and pl2, the percentages of pN0 patients were 89.1%, 76.9%, and 74.1%, respectively (pl0 vs. pl1, p = 0.002; pl0 vs. pl2, p = 0.02; pl1 vs. pl2, p = 0.83) (data not shown). Pl2 was previously reported to be a more significant prognostic factor for worse OS than pl1 in node-negative NSCLC with VPI [26,27]. In tumors ≤3 cm without lymph node metastasis in the current study, the 5-year OS rates of pl0, pl1, and pl2 patients were 86.6%, 81.6%, and 63.4%, respectively (pl0 vs. pl1, p = 0.80; pl0 vs. pl2, p = 0.008; pl1 vs. pl2, p = 0.14) (data not shown).…”
Section: Discussionmentioning
confidence: 97%